Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement.
RDIF chief Kirill Dmitriev said the deal will “provide the people of India with an efficient solution in this challenging period of the pandemic.” He added that Sputnik V should become “an integral part of the national vaccine portfolio” of every country.
DETAILS TO FOLLOW
© 2020, paradox. All rights reserved.
